| |
In the 2019 financial period, the Group had presented the taxation receivable net of its taxation payable obligations. The restatement has been performed to reflect the gross taxation view as this
is deemed to be more appropriate.
The table below illustrates the impact of the statement of financial position restatement:
| |
| |
|
|
|
| 1 085 620 |
32 279 |
1 117 899 |
|
| Trade and other receivables |
531 494 |
– |
531 494 |
|
| Cash and cash equivalents |
265 296 |
– |
265 296 |
|
| Inventory |
283 732 |
– |
283 732 |
|
| Current tax asset |
5 098 |
32 279 |
37 377 |
|
| 686 046 |
32 279 |
718 325 |
|
| Trade and other payables |
415 836 |
– |
415 836 |
|
| Borrowings |
120 000 |
– |
120 000 |
|
| Employment benefit liability |
88 659 |
– |
88 659 |
|
| Lease liability |
61 551 |
– |
61 551 |
|
| Taxation |
– |
32 279 |
32 279 |
|
|
|
| |
In the 2019 financial period, the Group had presented the courier costs associated with the delivery of medication by Pharmacy Direct to its clients as other expenses.
Due to the nature of these expenses, presenting these costs as cost of distribution of pharmaceutical products is deemed to be more appropriate. This reclassification did not have an impact on the
Group's profit nor any income statement ratios.
This has been corrected as follows:
| |
| |
|
|
|
| Cost of distribution of pharmaceutical products |
– |
(75 941) |
(75 941) |
|
| Other expenses |
(937 874) |
75 941 |
(861 933) |
|
|
|
| |
In 2019 financial period, the Group had erroneously included "ROU Lease adjustments on profits" in the cash generated from operations note. This correction has resulted in an increase on the cash earnings
per share as the calculation was based on the cash generated from operations per the note.
This has been corrected by restating as follows:
| |
| 528 487 |
|
528 487 |
|
| Adjustments for: |
|
|
|
|
| Fair value gain on disposal |
(118 715) |
|
(118 715) |
|
| Right of use lease adjustments on profits |
(94 474) |
94 474 |
– |
|
| Right of use assets depreciation |
82 666 |
|
82 666 |
|
| Interest on lease |
31 822 |
|
31 822 |
|
| Finance income |
(24 657) |
|
(24 657) |
|
| Finance cost |
20 186 |
|
20 186 |
|
| Bad debts written off |
3 602 |
|
3 602 |
|
| Increase/(decrease) in provision for bad debts |
326 |
|
326 |
|
| Net actuarial (gains)/losses |
(53) |
|
(53) |
|
| Depreciation |
55 909 |
|
55 909 |
|
| Fair value gains |
(12 867) |
|
(12 867) |
|
| Fair value of contingent consideration |
407 |
|
407 |
|
| Amortisation of intangible assets |
110 941 |
|
110 941 |
|
| Impairment of intangibles |
58 515 |
|
58 515 |
|
| Deferred payment reduction |
(5 263) |
|
(5 263) |
|
| Impairment provision on investments and loans |
9 746 |
|
9 746 |
|
| (Profit)/loss on disposal of investment |
4 694 |
|
4 694 |
|
| Loss on disposal of intangible assets |
40 000 |
|
40 000 |
|
| Interest relating to deferred payment balance |
1 697 |
|
1 697 |
|
| Share-based payment expense |
7 785 |
|
7 785 |
|
| Share of profit from associates |
(18 479) |
|
(18 479) |
|
| 682 275 |
|
776 749 |
|
| (113 213) |
|
(113 213) |
|
| Trade and other receivables |
(104 274) |
|
(104 274) |
|
| Provisions |
28 380 |
|
28 380 |
|
| Inventory |
(86 359) |
|
(86 359) |
|
| Trade and other payables |
49 040 |
|
49 040 |
|
|
| 569 062 |
94 474 |
663 536 |
|
|
| |
The cash earnings per share are calculated based on the cash generated from operations. In the prior year, the cash earnings per share were calculated based on an incorrectly disclosed cash generated
from operations amount per the note (see Note 35.3). On the restatement of the cash generated from operations note, the cash earnings per share was recalculated resulting in an increase in the previously
disclosed value.
This has been corrected by restating as follows:
| |
| |
|
|
| Basic |
101.47 |
16.84 |
118.31 |
| Diluted |
99.94 |
16.59 |
116.53 |
|
| |
In the prior year the unearned fees relating to the single exit price (SEP) pricing of the inventory at hand as at year end, were separately disclosed as merchandise provision in the inventory note,
consisting of rebate agreements with vendors relating to the purchase of the Group's inventory . However these are not provisions in nature, as these rebates represent a reduction in the cost of
Finished goods inventory. For improved disclosure, the prior year inventory note has been restated to reduce the cost of finished goods inventory by the unearned fees provision.
This has been corrected by restating as follow:
| |
| Finished goods |
234 233 |
(48 849) |
185 384 |
| Merchandise |
98 348 |
|
98 348 |
| Merchandise provision |
(48 849) |
48 849 |
– |
| |
283 732 |
– |
283 732 |
|
| |
In the 2019 financial statements, the lease liability capital repayment was incorrectly described as the lease liability interest repayment on the cash flow from financing activities. The 2019 financial statements have
been restated to reflect the correct line description.
Herewith is the effect of the restatement on the financial statements:
| Financial Statement Lime |
2019
As previously
reported |
Adjustment
(Increase)/
Decrease
R’000 |
2019
Restated
R’000 |
| Lease liability capital repayment |
– |
(62 652) |
(62 652) |
| Lease liability interest repayment |
(62 652) |
62 652 |
– |
This correction did not have any impact on the cash generated from financing activities, and subsequently did not have an impact on the cash and cash equivalents for the year. This correction did not have any impact on
the net profit position.
|